157 related articles for article (PubMed ID: 8512826)
1. Glutathione and glutathione S-transferases in Barrett's epithelium.
Peters WH; Roelofs HM; Hectors MP; Nagengast FM; Jansen JB
Br J Cancer; 1993 Jun; 67(6):1413-7. PubMed ID: 8512826
[TBL] [Abstract][Full Text] [Related]
2. Low glutathione and glutathione S-transferase levels in Barrett's esophagus as compared to normal esophageal epithelium.
van Lieshout EM; Tiemessen DM; Witteman BJ; Jansen JB; Peters WH
Jpn J Cancer Res; 1999 Jan; 90(1):81-5. PubMed ID: 10076569
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma.
Brabender J; Lord RV; Wickramasinghe K; Metzger R; Schneider PM; Park JM; Hölscher AH; DeMeester TR; Danenberg KD; Danenberg PV
J Gastrointest Surg; 2002; 6(3):359-67. PubMed ID: 12022988
[TBL] [Abstract][Full Text] [Related]
4. Alteration of glutathione S-transferase levels in Barrett's metaplasia compared to normal oesophageal epithelium.
Cobbe SC; Scobie GC; Pohler E; Hayes JD; Kernohan NM; Dillon JF
Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):41-7. PubMed ID: 12544693
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of glutathione S-transferase alpha and pi in human esophageal squamous epithelium, Barrett's epithelium and carcinoma.
van Lieshout EM; van Haelst UJ; Wobbes T; Peters WH
Jpn J Cancer Res; 1999 May; 90(5):530-5. PubMed ID: 10391093
[TBL] [Abstract][Full Text] [Related]
6. Induction of glutathione s-transferase-pi in Barrett's metaplasia and Barrett's adenocarcinoma cell lines.
Compton KR; Orringer MB; Beer DG
Mol Carcinog; 1999 Feb; 24(2):128-36. PubMed ID: 10078940
[TBL] [Abstract][Full Text] [Related]
7. Expression of glutathione s-transferase pi in benign mucosa, Barrett's metaplasia, and adenocarcinoma of the esophagus.
Chandra RK; Bentz BG; Haines GK; Robinson AM; Radosevich JA
Head Neck; 2002 Jun; 24(6):575-81. PubMed ID: 12112555
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferases in esophageal cancer.
Peters WH; Wobbes T; Roelofs HM; Jansen JB
Carcinogenesis; 1993 Jul; 14(7):1377-80. PubMed ID: 8330353
[TBL] [Abstract][Full Text] [Related]
9. Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma.
van Lieshout EM; Roelofs HM; Dekker S; Mulder CJ; Wobbes T; Jansen JB; Peters WH
Cancer Res; 1999 Feb; 59(3):586-9. PubMed ID: 9973204
[TBL] [Abstract][Full Text] [Related]
10. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study.
Buttar NS; Wang KK; Anderson MA; Dierkhising RA; Pacifico RJ; Krishnadath KK; Lutzke LS
J Natl Cancer Inst; 2002 Mar; 94(6):422-9. PubMed ID: 11904314
[TBL] [Abstract][Full Text] [Related]
11. Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.
Herszenyi L; Hritz I; Pregun I; Sipos F; Juhasz M; Molnar B; Tulassay Z
World J Gastroenterol; 2007 Feb; 13(5):676-82. PubMed ID: 17278189
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 expression in Barrett's esophagus.
Kandil HM; Tanner G; Smalley W; Halter S; Radhika A; Dubois RN
Dig Dis Sci; 2001 Apr; 46(4):785-9. PubMed ID: 11330414
[TBL] [Abstract][Full Text] [Related]
13. Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus.
Piaggi S; Marchi S; Ciancia E; Debortoli N; Lazzarotti A; Saviozzi M; Raggi C; Fierabracci V; Visvikis A; Bisgaard HC; Casini AF; Paolicchi A
Oncol Rep; 2009 Feb; 21(2):283-7. PubMed ID: 19148497
[TBL] [Abstract][Full Text] [Related]
14. ErbB2 without erbB3 expression in metaplastic columnar epithelium of Barrett's esophagus.
Nishigaki H; Wada K; Tatsuguchi A; Sueoka N; Futagami S; Gudis K; Miyake K; Tsukui T; Sakamoto C
Digestion; 2004; 70(2):95-102. PubMed ID: 15375338
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa.
Eda A; Osawa H; Satoh K; Yanaka I; Kihira K; Ishino Y; Mutoh H; Sugano K
J Gastroenterol; 2003; 38(1):14-22. PubMed ID: 12560917
[TBL] [Abstract][Full Text] [Related]
16. Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus.
Souza RF; Shewmake KL; Shen Y; Ramirez RD; Bullock JS; Hladik CL; Lee EL; Terada LS; Spechler SJ
Am J Gastroenterol; 2005 Mar; 100(3):551-9. PubMed ID: 15743351
[TBL] [Abstract][Full Text] [Related]
17. Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium.
Tharalson EF; Martinez SD; Garewal HS; Sampliner RE; Cui H; Pulliam G; Fass R
Am J Gastroenterol; 2002 Apr; 97(4):851-6. PubMed ID: 12003418
[TBL] [Abstract][Full Text] [Related]
18. Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study.
Levine DS; Rubin CE; Reid BJ; Haggitt RC
Lab Invest; 1989 Mar; 60(3):418-32. PubMed ID: 2927081
[TBL] [Abstract][Full Text] [Related]
19. Distinct immunohistochemical findings in columnar epithelium of esophageal inlet patch and of Barrett's esophagus.
Feurle GE; Helmstaedter V; Buehring A; Bettendorf U; Eckardt VF
Dig Dis Sci; 1990 Jan; 35(1):86-92. PubMed ID: 2295298
[TBL] [Abstract][Full Text] [Related]
20. Glutathione peroxidase isoforms as part of the local antioxidative defense system in normal and Barrett's esophagus.
Mörk H; Scheurlen M; Al-Taie O; Zierer A; Kraus M; Schöttker K; Jakob F; Köhrle J
Int J Cancer; 2003 Jun; 105(3):300-4. PubMed ID: 12704661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
